NasdaqCM - Nasdaq Real Time Price USD
Immuron Limited (IMRN)
1.7342
+0.0442
+(2.62%)
As of 10:09:20 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IMRN | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
| Initiated | Litchfield Hills: Buy | 9/26/2024 |
| Initiated | HC Wainwright & Co.: Buy | 10/18/2017 |
Related Tickers
NLSP NLS Pharmaceutics AG
2.5600
-6.91%
GLTO Galecto, Inc.
3.3514
+1.87%
KZR Kezar Life Sciences, Inc.
4.6000
+3.37%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.1906
-2.65%
EDSA Edesa Biotech, Inc.
1.9138
-2.36%
HOTH Hoth Therapeutics, Inc.
1.2102
+1.68%
NXTC NextCure, Inc.
0.5199
-1.63%
VTVT vTv Therapeutics Inc.
16.09
-3.15%
XBIO Xenetic Biosciences, Inc.
3.1000
-1.43%
SABS SAB Biotherapeutics, Inc.
1.8400
-1.10%